Articles

"What Makes You Love an Industry for 15 Years?" | A Conversation with Wang Tianfan: I Want to Invest in True Joy, the Purest Vision, and the Brilliance of Human Nature [Highway Podcast]

"What Makes You Love an Industry for 15 Years?" | A Conversation with Wang Tianfan: I Want to Invest in True Joy, the Purest Vision, and the Brilliance of Human Nature [Highway Podcast]

🚥 **15 years of investing and passion — what's the underlying drive?** Will 2026 still be a good year to bet on AI applications and AI hardware? When everyone knows there's a bubble right now, what should you chase and what should you let go?

十字路口Crossing·
Meituan's LLM Is as Free as Its Delivery Service

Meituan's LLM Is as Free as Its Delivery Service

AI app builders are running out of road. The scales of victory have tipped once again toward the foundation model companies. In light of this, we're bringing back our tribute to "Burying AI" — a year-old series where we profiled the model makers one by one.

葬AI·
Weilan Stellar completes hundreds of millions of RMB in angel+ funding round, racing to build world's first high-temperature superconducting stellarator

Weilan Stellar completes hundreds of millions of RMB in angel+ funding round, racing to build world's first high-temperature superconducting stellarator

In the race for controllable nuclear fusion, a young company is stepping into the spotlight. **BlueStar Fusion, a Hefei-based startup focused on stellarator fusion, has officially announced the completion of its angel+ round, raising several hundred million RMB. The proceeds will primarily fund the construction of the world's first high-temperature superconducting stellarator. Gaorong Ventures, which participated in the company's angel round, significantly increased its investment in this round.**

高榕创投·
NewPro Closes Tens of Millions of RMB in Pre-A Funding Led by Dalton Venture and SSCI Leading Fund, Achieves FDA Self-GRAS Certification for Self-Developed Lactoferrin | Dalton Venture News

NewPro Closes Tens of Millions of RMB in Pre-A Funding Led by Dalton Venture and SSCI Leading Fund, Achieves FDA Self-GRAS Certification for Self-Developed Lactoferrin | Dalton Venture News

Recently, **NewPro Bioworks (Shanghai Xinyicui Biotechnology Co., Ltd.) announced the completion of a Pre-A funding round worth tens of millions of RMB**. This round was jointly led by **SSCI Leading Fund and Aochuang Pioneer Fund — the latter established by Dalton Venture in partnership with listed industry player OPM Biosciences, making it the first bio-manufacturing industry CVC fund in the Yangtze River Delta region**. Meanwhile, the company's self-developed precision-fermented lactoferrin product

道彤投资·
Dalton Venture Backs Invasive BCI, Active Technologies' 330 Million Yuan Angel Round Sets New Domestic Record for Brain-Computer Interface Funding | Dalton News

Dalton Venture Backs Invasive BCI, Active Technologies' 330 Million Yuan Angel Round Sets New Domestic Record for Brain-Computer Interface Funding | Dalton News

On August 3, **Shanghai Initiative Technology Co., Ltd. (hereinafter referred to as "Initiative Technology") announced the completion of a 330 million RMB angel funding round, setting a new record for angel-round financing in China's brain-computer interface sector. This round was led by CASSTAR, with co-investment from Dalton Venture, Legend Star, Unity Ventures, Inno Angel Fund, BGI Songhe Bio Fund, LYFE Capital, and Jiadao Capital**. The proceeds will be mainly used for facility expansion, equipment upgrades, and clinical trial advancement.

道彤投资·